Immunogenicity and safety study of a third measles mumps rubella (MMR-3) vaccine dose in healthy young adults in The Netherlands
Latest Information Update: 20 Feb 2024
At a glance
- Drugs Measles mumps and rubella virus vaccine (Primary)
- Indications Measles; Mumps; Rubella
- Focus Pharmacodynamics
- Acronyms MMR-3
- 03 Nov 2021 Status changed from recruiting to completed.
- 22 Jun 2016 New trial record